Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions

被引:20
作者
Moghimi, S. Moein [1 ,2 ,3 ]
Haroon, Hajira B. [2 ]
Yaghmur, Anan [4 ]
Hunter, A. Christy [5 ]
Papini, Emanuele [6 ]
Farhangrazi, Z. Shadi [7 ,8 ]
Simberg, Dmitri [3 ,9 ]
Trohopoulos, Panagiotis N. [10 ]
机构
[1] Newcastle Univ, Sch Pharm, Newcastle Upon Tyne NE1 7RU, England
[2] Newcastle Univ, Translat & Clin Res Inst, Fac Hlth & Med Sci, Newcastle Upon Tyne NE2 4HH, England
[3] Univ Colorado, Anschutz Med Ctr, Colorado Ctr Nanomed & Nanosafety, Aurora, CO USA
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, DK-2100 Copenhagen, Denmark
[5] Univ Lincoln, Coll Sci, Sch Pharm, Lincoln LN6 7TS, England
[6] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy
[7] S M Discovery Grp Inc, Centennial, CO USA
[8] S M Discovery Grp Ltd, Durham, England
[9] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Anschutz Med Ctr,Translat Bionanosciences Lab, Aurora, CO USA
[10] CosmoPHOS Ltd, 77 Tsimiski St, Thessaloniki 54622, Greece
关键词
Adverse reactions; Complement system; Dendrimers; Macrophage; Nanoparticles; NanoLigand carriers; Opsonisation; Pseudoviral nanoparticles phagocytosis; PULMONARY INTRAVASCULAR MACROPHAGES; LARGE UNILAMELLAR LIPOSOMES; ALTERNATIVE PATHWAY; PROTEIN CORONA; HUMAN SERUM; BLOOD COMPONENTS; ARCHAEAL VIRUSES; PLASMA-PROTEINS; LUNG INJURY; IN-VIVO;
D O I
10.1016/j.jconrel.2023.02.022
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The complement system, professional phagocytes and other cells such as Natural killer cells and mast cells are among the important components of the innate arm of the immune system. These constituents provide an orchestrated array of defences and responses against tissue injury and foreign particles, including nano -pharmaceuticals. While interception of nanopharmaceuticals by the immune system is beneficial for immuno-modulation and treatment of phagocytic cell disorders, it is imperative to understand the multifaceted mechanisms by which nanopharmaceuticals interacts with the immune system and evaluate the subsequent balance of beneficial versus adverse reactions. An example of the latter is adverse infusion reactions to regulatory-approved nanopharmaceuticals seen in human subjects. Here, we discuss collective opinions and findings from our laboratories in mapping nanoparticle-mediated complement and leucocyte/macrophage responses.
引用
收藏
页码:115 / 129
页数:15
相关论文
共 155 条
[1]   Complement Receptor-Mediated Phagocytosis Induces Proinflammatory Cytokine Production in Murine Macrophages [J].
Acharya, Durga ;
Li, Xiao Rui ;
Heineman, Rebecca Emily-Sue ;
Harrison, Rene E. .
FRONTIERS IN IMMUNOLOGY, 2020, 10
[2]   LIGATED COMPLEMENT RECEPTORS DO NOT ACTIVATE THE ARACHIDONIC-ACID CASCADE IN RESIDENT PERITONEAL-MACROPHAGES [J].
ADEREM, AA ;
WRIGHT, SD ;
SILVERSTEIN, SC ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (03) :617-622
[3]   ANTIBODY BINDING AND COMPLEMENT FIXATION BY A LIPOSOMAL MODEL MEMBRANE [J].
ALVING, CR ;
KINSKY, SC ;
HAXBY, JA ;
KINSKY, CB .
BIOCHEMISTRY, 1969, 8 (04) :1582-&
[4]   Targeting Macrophages: Friends or Foes in Disease? [J].
Ardura, Juan A. ;
Rackov, Gorjana ;
Izquierdo, Elena ;
Alonso, Veronica ;
Gortazar, Arancha R. ;
Escribese, Maria M. .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[5]   Human serum IgM glycosylation - Identification of glycoforms that can bind to mannan-binding lectin [J].
Arnold, JN ;
Wormald, MR ;
Suter, DM ;
Radcliffe, CM ;
Harvey, DJ ;
Dwek, RA ;
Rudd, PM ;
Sim, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) :29080-29087
[6]   SEXUAL DIMORPHISM OF THE 5TH COMPONENT OF MOUSE COMPLEMENT [J].
BABA, A ;
FUJITA, T ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :411-419
[7]   Complement activation, regulation, and molecular basis for complement-related diseases [J].
Bajic, Goran ;
Degn, Soren E. ;
Thiel, Steffen ;
Andersen, Gregers R. .
EMBO JOURNAL, 2015, 34 (22) :2735-2757
[8]  
Banerjee S., 2019, PRECIS NANOMED, V2, P278, DOI [10.33218/prnano2 (2).190411.1, DOI 10.33218/PRNANO2(2).190411.1]
[9]   Anti-PEG antibodies before and after a first dose of Comirnaty? (mRNA-LNP-based SARS-CoV-2 vaccine) [J].
Bavli, Yaelle ;
Chen, Bing-Mae ;
Gross, Guy ;
Hershko, Alon ;
Turjeman, Keren ;
Roffler, Steve ;
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2023, 354 :316-322
[10]   Hypersensitivity Reactions to Intravenous Lipid Emulsion in Swine: Relevance for Lipid Resuscitation Studies [J].
Bedocs, Peter ;
Capacchione, John ;
Potts, Lauren ;
Chugani, Ryan ;
Weiszhar, Zsoka ;
Szebeni, Janos ;
Buckenmaier, Chester C. .
ANESTHESIA AND ANALGESIA, 2014, 119 (05) :1094-1101